Seraxis Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Seraxis Inc. - overview
Established
2013
Location
Germantown, MD, US
Primary Industry
Biotechnology
About
Founded in 2013 and based in Germantown, Maryland, Seraxis Inc. operates as a biotechnology company that focuses on cell therapy treatment for diabetes. Mr. William L.
Rust is the CEO and co-founder of the company and Miss Carole Welsch is the co-founder and chief business officer. In March 2013, the company raised an undisclosed amount in series A funding from new investors ASAP Ventures, GRI Fund, L. P. and East West Capital Partners.
Seraxis team of scientists developed novel cell and encapsulation technologies. The company provides insulin-dependent diabetes. The company develops SR1423 cells, lab-grown islets for transplant and SeraGraft © device. The company has also developed SeraGraft, an implant device and method that enables survival and function of the cell replacement therapy in the absence of immune suppression.
The company will focus on completing the preclinical testing of SR-01, Seraxis’ lead cell therapy treatment for insulin-dependent diabetes and initiate first-in-human clinical trials.
Current Investors
East West Capital Partners, ASAP Ventures, GRI Fund, L.P.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Website
www.seraxis.com
Verticals
Manufacturing
Company Stage
Series C
Total Amount Raised
Subscriber access only
Seraxis Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.